'I Can't Wait' is the Campaign Theme for World Hepatitis Day 2022
28 juil. 2022 00h15 HE
|
World Hepatitis Alliance
LONDON, England, July 28, 2022 (GLOBE NEWSWIRE) -- Today, World Hepatitis Day (WHD) launches with the campaign theme 'I Can't Wait'. On WHD, the World Hepatitis Alliance (WHA) joins together with...
Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for Ebola
07 juil. 2022 16h30 HE
|
Emergent BioSolutions
GAITHERSBURG, Md. and MIAMI, July 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement with Ridgeback Biotherapeutics (“Ridgeback...
BioNTech beginnt Bau der ersten Produktionsstätte für mRNA-basierte Impfstoffe in Afrika
23 juin 2022 06h00 HE
|
BioNTech SE
Spatenstich in Kigali, Ruanda, für BioNTechs erste modulare mRNA-Produktionsstätte in Afrika; Lieferung der ersten Containermodule für Ende 2022 geplantAuf Einladung von Paul Kagame, Präsident der...
BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
23 juin 2022 06h00 HE
|
BioNTech SE
Breaking of Ground for BioNTech’s initial African modular mRNA manufacturing facility in Kigali, Rwanda; delivery of first container modules planned for end of 2022On invitation by H.E. President Paul...
BioNTech gibt Update zu Plänen für Produktion und Entwicklung von mRNA-Impfstoffen in Afrika
09 juin 2022 08h31 HE
|
BioNTech SE
MAINZ, Deutschland, 9. Juni 2022 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, „BioNTech“) wird ihre afrikanischen Partner zum ersten Mal auf dem afrikanischen Kontinent begrüßen und dort über den...
BioNTech to Provide an Update on Manufacturing and Development Plans of mRNA Vaccines in Africa
09 juin 2022 08h31 HE
|
BioNTech SE
MAINZ, Germany, June 9, 2022 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech”) will welcome its African partners for the first time on the African continent and provide an update on the joint...
Isothermal Nucleic Acid Amplification Technology Market to cross USD 2.8 Billion by 2028: Global Market Insights Inc.
20 avr. 2022 06h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware , April 20, 2022 (GLOBE NEWSWIRE) -- The isothermal nucleic acid amplification technology (INAAT) market value is projected to reach USD 2.8 billion by 2028, according to a...
BioAegis Therapeutics Completes $22 Million Institutional Sale of Equity in a Non-Brokered Transaction
22 mars 2022 05h00 HE
|
BioAegis Therapeutics
NORTH BRUNSWICK, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage, private company developing therapies for inflammatory, infectious, and degenerative diseases...
Dr. William Haseltine releases new book on Innate Immunity and Covid-19
16 mars 2022 13h37 HE
|
ACCESS Health International
New York, March 16, 2022 (GLOBE NEWSWIRE) -- In his latest book, bestselling author William A. Haseltine Ph.D. tells us that understanding our natural immunity to the SARS-CoV-2 virus is critical...
BioAegis Therapeutics Announces Appointment of Two New Corporate Board Members
17 févr. 2022 17h42 HE
|
BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Feb. 17, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage, private company developing therapies for inflammatory, infectious, and degenerative diseases...